Immunexpress
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
425 Pontius Ave N Ste 470, Seattle, Wash...Phone Number
(206) 858-6436Website
www.immunexpress.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Immunexpress
Immunexpress is a molecular diagnostic company, based out of Seattle, committed to improving outcomes for patients suspected of sepsis. Immunexpress' SeptiCyte® technology can assess a patient's dysregulated immune response by quantifying and analyzing gene expression from whole blood, providing actionable results in about an hour to guide the physician in optimizing patient management decisions. SeptiCyte® RAPID is a lab test for sepsis that combines SeptiCyte® technology with the Biocartis' Idylla platform*, empowering clinicians to swiftly differentiate infection positive (sepsis) from infection negative systemic inflammation in patients suspected of sepsis; diagnosing bacterial sepsis, viral sepsis, or fungal infections. This powerful combination of technologies enhances certainty for early sepsis diagnosis, to improve clinical outcomes and lower healthcare costs. In March 2020, Immunexpress received CE Marking of SeptiCyte® RAPID and announced a commercialization partnership withRead more
Immunexpress Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immunexpress your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Immunexpress has new funding data
Immunexpress, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Immunexpress launches new products
Check out if Immunexpress is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Immunexpress
Earning: See what the market has to say on Immunexpress recently announced quarterly report
Click to see if Immunexpress had a recent Job posting/layoffs
Check if Immunexpress has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Immunexpress
Compare insights from companies similar to Immunexpress, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Immunexpress is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Immunexpress is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Immunexpress.
Immunexpress Tech Stack
A closer look at the technologies used by Immunexpress
Immunexpress News & Media
Immunexpress Announces Publication Demonstrating SeptiCyte RAPID® Utility for Differentiating Infection from Sterile Inflammation in Readmitted Bone Marrow Transplant Patients with Febrile Neutropaenia
Study supports utility of host-response testing in febrile neutropenia patients with haematological malignancies which may be the only indication of severe underlying infections SEATTLE and BRISBANE, Australia, Feb. 25, 2026 /PRNewswire/ -- Immunexpress, a molecular diagnostics company...Immunexpress Announces Publication Showing SeptiCyte RAPID® Identifies Septic Patients Most Likely to Have Positive Blood Cultures
Publication highlights strong association between a patient's sepsis risk and likelihood of positive cultures, with SeptiCyte RAPID results just 90 minutes after a blood draw SEATTLE and BRISBANE, Australia, Feb. 12, 2026 /PRNewswire/ -- Immunexpress, a molecular diagnostics company...2 New Published Studies Highlight SeptiCyte RAPID's Strong Performance and Clinical Utility in Post Cardiac Surgery Patients
SeptiCyte® RAPID scales with other measures of infection and clinical severity and outperforms traditional biomarkers in discriminating infection status SEATTLE and BRISBANE, Australia, Oct. 23, 2025 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostic company focused on...Study Published in the Journal Infection Demonstrates Clinical Utility of SeptiCyte® RAPID to Diagnose Sepsis in Critically Ill Patients with Hospital Acquired Infections
SeptiCyte® RAPID outperformed traditional inflammatory biomarkers of procalcitonin and C-reactive protein SEATTLE and BRISBANE, Australia, Sept. 17, 2025 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients,...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Immunexpress
Sign Up For FreeTo access detailed company insights
Immunexpress is a molecular diagnostic company, based out of Seattle, committed to improving outcomes for patients suspected of sepsis. Immunexpress' SeptiCyte® technology can assess a patient's dysregulated immune response by quantifying and analyzing gene expression from whole blood, providing actionable results in about an hour to guide the phys... Read More
